Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection

MONDO:0011409

Also known as: hepatic fibrosis susceptibility due to schistosoma mansoni infection, hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection, Sm2, hepatic fibrosis, Severe, susceptibility to, due to Schistosoma japonicum infection

1 clinical trial for this condition and its sub-types, 1 tagged with Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Inherited disease susceptibility (1314)

Including sub-types (1) Tagged with Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection (1)

Not yet recruiting 1

Can extra doses of an old drug reverse liver scarring?

Disease control Not yet recruiting

This trial tests whether giving praziquantel three times a year, instead of the standard once a year, can improve liver fibrosis (scarring) caused by schistosomiasis in people aged 15-40 in Uganda. Participants with liver fibrosis will be randomly assigned to one of two treatment…

Phase 2/3 • Sponsor: Rhode Island Hospital • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC

Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection

Where it sits in the disease tree

Can extra doses of an old drug reverse liver scarring?